# Amneal Pharmaceuticals, Inc.: Form 8-K, filed Nov 7, 2018

- Company: [Amneal Pharmaceuticals, Inc.](/companies/amrx.md) (CIK 1723128)
- Form: 8-K
- Filed: 2018-11-07
- Accepted by EDGAR: Nov 7, 2018, 07:02 ET
- Period: 2018-11-07
- Accession: 0001723128-18-000035
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1723128/000172312818000035/amrxform8-k11x7x18.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1723128/000172312818000035/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1723128/000172312818000035/amrxform8-k11x7x18.htm

Filed Nov 7, 2018.
Source: SEC EDGAR, the filing index for accession 0001723128-18-000035. Last ingested by Listed: Nov 10, 2026, 02:45 ET. No prices; not investment advice.
